# Esplanade HealthTech Ventures

Esplanade HealthTech Ventures is a Venture Capital based in Westmount, Canada.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Westmount, Canada
- **Region:** North America
- **Address:** Westmount, Montreal, Canada
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** esplanadeventures.com
- **LinkedIn:** https://ca.linkedin.com/company/esplanadeventures

## Regulatory record

- **Reports private funds:** No

## About

Esplanade Ventures is Canada's leading digital health VC, investing early in technology companies transforming care across the U.S. and Canada. The firm is made up of healthcare operators, founders, and investors with over 100 years of collective experience. They invest in early-stage and high-growth companies redefining healthcare delivery, with a focus on digital health and preference for AI software, and support portfolio companies with hands-on guidance, commercial introductions, and GTM strategy.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML
- Medical Devices

## People

- Dr. Sheldon Elman — MD — Co-Founder & Chairman
- Stuart M. Elman — Co-Founder
- Josh Blair — Venture Partner
- Ella Seitz — Managing Partner
- Alexandre Nossovskoi — Principal
- Kavuchaljan Ganesathasan — VP Finance
- Simon Kennedy — Senior Advisor
- Dr. Yosef Berlyand — MD — Advisor

## Questions

### How does the firm source its health-technology deal flow?

Esplanade derives deal flow from Quebec's dense academic-medical research cluster, including McGill University and the Université de Montréal health networks. This proximity to publicly funded clinical science gives the firm early exposure to spin-out intellectual property before it reaches broader auction-market processes.

### Does Esplanade lead investment rounds or co-invest alongside other funds?

The firm is structured to lead or co-lead early-stage rounds and will participate alongside other specialized health-tech or generalist venture funds. Its strategy does not preclude syndication with larger later-stage investors when portfolio companies progress beyond Series A.

### Which health-tech subsectors does Esplanade explicitly avoid?

Based on its disclosed focus and typical investment profile, the firm does not appear to pursue biopharmaceutical drug development, large-scale hospital buyouts, or health-service businesses lacking a proprietary technology or device layer. Its activity is centered on digital health platforms, AI diagnostics, and regulated medical devices.

## Related profiles

- [Eqvitec Partners](https://altss.com/profile/eqvitec-partners)
- [Essex Woodlands](https://altss.com/profile/essex-woodlands)

---

Last updated: 2026-08-11T15:06:42.396Z

Canonical page: https://altss.com/profile/esplanade-healthtech-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology